To diagnose NMO, other conditions, particularly multiple sclerosis (MS), anti-myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease, and sarcoidosis, need to be excluded. This evidence concerns the gene MOG and myeloid sarcoma.